Cargando…
Cadherin switching in oral squamous cell carcinoma: A clinicopathological study
BACKGROUND AND AIM: Oral squamous cell carcinoma (OSCC) is one of the most common malignancies worldwide as it represents the sixth most common cancer. Numerous molecular mechanisms have been explained to regulate OSCC progression, including epithelial-mesenchymal transition (EMT). Cadherin switchin...
Autores principales: | Ali, Ahmed Noaman, Ghoneim, Shoukria Mohammed, Ahmed, Esam Rashwan, El-Farouk Abdel Salam, Lubna Omar, Anis Saleh, Sanaa Mahmoud |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10245331/ https://www.ncbi.nlm.nih.gov/pubmed/37293580 http://dx.doi.org/10.1016/j.jobcr.2023.05.001 |
Ejemplares similares
-
Progression of Oral Squamous Cell Carcinoma Accompanied with Reduced E-Cadherin Expression but Not Cadherin Switch
por: Hashimoto, Takashi, et al.
Publicado: (2012) -
Pyogenic granuloma: Clinicopathological and treatment scenario
por: Al-Noaman, Ahmed Salah
Publicado: (2020) -
Clinicopathological significance of ZEB-1 and E-cadherin proteins in patients with oral cavity squamous cell carcinoma
por: Yao, Xiaofeng, et al.
Publicado: (2017) -
Immunohistochemical Expression of E-Cadherin and β-Catenin in Oral Squamous Cell Carcinoma
por: Akinyamoju, Akindayo Olufunto, et al.
Publicado: (2023) -
Clinicopathological significance and potential drug target of T-cadherin in NSCLC
por: Wang, Zhidong, et al.
Publicado: (2014)